fbpx
June 9, 2025

Real-World Evidence

FDA has a long history of using what we currently call real-world data (RWD) and real-world evidence (RWE) to monitor and evaluate the postmarket safety of […]
June 6, 2025

Q&A with FDA Podcast

“Q&A with FDA” provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of […]
June 4, 2025

New Drug Therapy Approvals 2022

INNOVATION   PREDICTABILITY   ACCESSFDA’s Center for Drug Evaluation and ResearchJanuary 2023 Table of Contents Director’s Message Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research Welcome […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0